Verified Nov 2026
Other
·

Istanbul, Istanbul
·
Since 1983
Sanovel İlaç is a Turkish pharmaceutical manufacturer founded in 1983 and headquartered in Istanbul. The privately held company employs 1,000–5,000 staff and produces over 180 branded-generic products across cardiovascular, respiratory, gastrointestinal, and veterinary therapeutic areas. It operates a manufacturing and R&D campus in Silivri with annual capacity of 227 million units and exports to over 40 countries. In 2026, the company expanded into urology as a new therapeutic focus.
Sanovel İlaç at a glance
Employees
1,000-5,000
Founded
1983
Headquarters
Istanbul, Istanbul
Industries
Automotive
Electric Vehicles
Medical
Overview
Sanovel İlaç is a Turkish pharmaceutical manufacturer founded in 1983 and headquartered in Istanbul. The privately held company employs 1,000–5,000 staff and produces over 180 branded-generic products across cardiovascular, respiratory, gastrointestinal, and veterinary therapeutic areas. It operates a manufacturing and R&D campus in Silivri with annual capacity of 227 million units and exports to over 40 countries. In 2026, the company expanded into urology as a new therapeutic focus.
At a glance
Attribute | Detail |
|---|---|
Founded | 1983 |
Headquarters | Istanbul, Istanbul |
Employees | 1,000-5,000 |
What Sanovel İlaç makes
The company manufactures over 180 pharmaceutical formulations including tablets, syrups, creams, and sterile injectables, with products across multiple therapeutic areas and veterinary pharmaceuticals.
Latest developments
2026-10-05 — Sanovel, 40 Yılı Aşan Deneyimini Üroloji Alanına Taşıyor — Turkchem.net (turkchem.net)
2026-10-05 — Sanovel faaliyet alanlarına ürolojiyi da ekledi - Genel Ekonomi- Ekonominin Nabzını Tutun (genelekonomi.com)
2026-08-04 — Sanovel Strengthens Global Position with International Investments - ChemEx World (chemexworld.com)
2026-08-04 — Sanovel uluslararası yatırımlarla küresel pazarlardaki konumunu güçlendiriyor – Sanayi Haber Ajansı / Industry News Agency (sanayihaberajansi.com.tr)
2026-06-09 — Sanovel CFO’luğuna Gökdeniz Gür atandı (ekonomigazetesi.com)
2025-12-05 — Türkiye ilaç sektöründe yenilikçi vizyonu ve güçlü Ar-Ge yatırımlarıyla öne çıkan Sanovel İlaç için Anton Paar XRDynamic500 cihazımızın kurulumu ve kullanıcı eğitimleri başarıyla tamamlandı. 🚀 | Anton Paar Türkiye (linkedin.com)
Company details
Sanovel is 100% Turkish-capital owned and serves both domestic healthcare consumers and international partners through licensing agreements across more than 40 countries. Sanovel İlaç was founded in 1983, has an estimated 1,000-5,000 employees, and is headquartered in Istanbul, Istanbul.
Frequently asked questions
What does Sanovel İlaç do?
Sanovel İlaç is a Turkish pharmaceutical manufacturer founded in 1983 and headquartered in Istanbul. The privately held company employs 1,000–5,000 staff and produces over 180 branded-generic products across cardiovascular, respiratory, gastrointestinal, and veterinary therapeutic areas. It operates a manufacturing and R&D campus in Silivri with annual capacity of 227 million units and exports to over 40 countries. In 2026, the company expanded into urology as a new therapeutic focus.
Where is Sanovel İlaç headquartered?
Sanovel İlaç is headquartered in Istanbul, Istanbul.
When was Sanovel İlaç founded?
Sanovel İlaç was founded in 1983.
How big is Sanovel İlaç?
Sanovel İlaç has an estimated 1,000-5,000 employees.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
